−705 KRW
−37.30 B KRW
95.55 B KRW
35.50 M
About CELLUMED CO., LTD.
Sector
Industry
CEO
In-Soo Yoo
Website
Headquarters
Seoul
Founded
1985
ISIN
KR7049180003
FIGI
BBG000MR2PH9
CELLUMED Co., Ltd. engages in the manufacture and distribution of medical device and biomaterials. Its products include holders for operations, biologics, artificial joints, and others. The company was founded on April 30, 1985 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 049180 is 2,050 KRW — it has decreased by −2.61% in the past 24 hours. Watch CELLUMED CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CELLUMED CO., LTD. stocks are traded under the ticker 049180.
049180 stock has fallen by −3.30% compared to the previous week, the month change is a −13.87% fall, over the last year CELLUMED CO., LTD. has showed a −7.03% decrease.
049180 reached its all-time high on May 22, 2006 with the price of 315,855 KRW, and its all-time low was 1,350 KRW and was reached on Aug 5, 2024. View more price dynamics on 049180 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
049180 stock is 4.66% volatile and has beta coefficient of −1.58. Track CELLUMED CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is CELLUMED CO., LTD. there?
Today CELLUMED CO., LTD. has the market capitalization of 105.59 B, it has increased by 0.23% over the last week.
Yes, you can track CELLUMED CO., LTD. financials in yearly and quarterly reports right on TradingView.
049180 net income for the last quarter is −1.95 B KRW, while the quarter before that showed −2.70 B KRW of net income which accounts for 27.73% change. Track more CELLUMED CO., LTD. financial stats to get the full picture.
No, 049180 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 104.00 employees. See our rating of the largest employees — is CELLUMED CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLUMED CO., LTD. EBITDA is −14.65 B KRW, and current EBITDA margin is −22.36%. See more stats in CELLUMED CO., LTD. financial statements.
Like other stocks, 049180 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLUMED CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLUMED CO., LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLUMED CO., LTD. stock shows the sell signal. See more of CELLUMED CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.